These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25115512)

  • 21. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
    Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human BSAP and BLIMP1 conform an autoregulatory feedback loop.
    Mora-López F; Reales E; Brieva JA; Campos-Caro A
    Blood; 2007 Nov; 110(9):3150-7. PubMed ID: 17682124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.
    Franco R; Scognamiglio G; Valentino E; Vitiello M; Luciano A; Palma G; Arra C; La Mantia E; Panico L; Tenneriello V; Pinto A; Frigeri F; Capobianco G; Botti G; Cerchia L; De Chiara A; Fedele M
    Oncotarget; 2016 Sep; 7(37):59158-59172. PubMed ID: 27494852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
    Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
    Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.
    Mandelbaum J; Bhagat G; Tang H; Mo T; Brahmachary M; Shen Q; Chadburn A; Rajewsky K; Tarakhovsky A; Pasqualucci L; Dalla-Favera R
    Cancer Cell; 2010 Dec; 18(6):568-79. PubMed ID: 21156281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.
    Baytak E; Gong Q; Akman B; Yuan H; Chan WC; Küçük C
    Tumour Biol; 2017 May; 39(5):1010428317701648. PubMed ID: 28468592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas.
    Petrakis G; Kostopoulos I; Venizelos I; Lambropoulou M; Vouras K; Vakalopoulou S; Mandala E; Tsatalas C; Papadopoulos N
    Histol Histopathol; 2017 Aug; 32(8):825-834. PubMed ID: 27924626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues.
    John SA; Garrett-Sinha LA
    Exp Cell Res; 2009 Apr; 315(7):1077-84. PubMed ID: 19073176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 35. PRDM1 is a tumor suppressor gene in natural killer cell malignancies.
    Küçük C; Iqbal J; Hu X; Gaulard P; De Leval L; Srivastava G; Au WY; McKeithan TW; Chan WC
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20119-24. PubMed ID: 22143801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.
    Thelander EF; Ichimura K; Corcoran M; Barbany G; Nordgren A; Heyman M; Berglund M; Mungall A; Rosenquist R; Collins VP; Grandér D; Larsson C; Lagercrantz S
    Leuk Lymphoma; 2008 Mar; 49(3):477-87. PubMed ID: 18297524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
    Wilkinson ST; Vanpatten KA; Fernandez DR; Brunhoeber P; Garsha KE; Glinsmann-Gibson BJ; Grogan TM; Teruya-Feldstein J; Rimsza LM
    Blood; 2012 Feb; 119(6):1459-67. PubMed ID: 22167754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
    Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
    Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
    Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
    Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.
    Nance JP; Bélanger S; Johnston RJ; Hu JK; Takemori T; Crotty S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13324-9. PubMed ID: 26460037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.